These new findings strengthen our understanding of the mechanisms underlying the role of the 5-HT/SNRPG/CDK14 axis in regulating NSCLC cell behavior and provide a theoretical basis for the development of therapeutic strategies targeting this pathway. This evidence concerns the gene SNRPG and non-small cell lung carcinoma.